Publications: MRSA
(Methicillin-resistant Staphylococcus aureus)
2006 to Present:
- Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R. Risk factors for community-associated Staphylococcus aureus infections: Results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiol Infect. 2010;1:1-11.
- Kallen A, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Healthcare-Associated Invasive MRSA Infections, 2005-2008. JAMA. 2010;304(6):641-48.
- Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia. Journal of Infection. 2010;61:372-81.
- Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, et al. Comparison of Incidence of Bloodstream Infection with Methicillin-Resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010;51(8):925-28.
- Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, et al. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J Clin Microbiol. 2010;48(10):3582-92.
- Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009;47(5):1344-51.
- Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, et al. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through the use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine 2009;27(37):5061-68.
- Buck JM, Harriman KH, Juni BA, Gall K, Boxrud DJ, Glennen A, et al. No change in methicillin-resistant Staphylococcus aureus nasal colonization rates among Minnesota school children during 2 study periods. Infect Dis Clin Pract 2008;16(3):163-5.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008.
- Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, et al. Characterization of Staphylococcus aureus Isolates from Nasal Cultures Collected from Individuals in the United States in 2001 to 2004. J Clin Microbiol 2008; 46(9):2837-41.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2007.
- Klevens MR, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. JAMA 2007; 298(15):1763-71.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2006.
- Klevens MR, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, et al. Community-associate Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors. Emerg Infec Dis 2006;12:1991-3.
- Buck JM, Como-Sabetti K, Harriman KH, Danila RN, Boxrud DJ, Glennen A, Lynfield R. Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis. 2005; 11(10):1532-8.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2005.
- Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
- Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
- Morin C, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in four metropolitan areas in Connecticut, 1998. J Infect Dis 2001;184:1029-34.
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov


